70P Optimizing second-line therapy for advanced gastrointestinal stromal tumors: Real-world efficacy and safety analysis

Ripretinib has emerged as a promising second-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs), demonstrating comparable efficacy to sunitinib and a superior safety profile. However, the optimal second-line therapy tailored to individual patient characteristics remains underexplored. This prospective, multicenter, observational study (NCT05440357) aims to evaluate real-world patterns and outcomes for GISTs patients.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-03-01
DOI
https://doi.org/10.1016/j.esmoop.2025.104384
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

70P Optimizing second-line therapy for advanced gastrointestinal stromal tumors: Real-world efficacy and safety analysis

Xiaodong Feng, Lijun Fan, Aiping Chen, J. Zhang et al.
ESMO Open
Gastrointestinal Tumor Research and Treatment
article

70P Optimizing second-line therapy for advanced gastrointestinal stromal tumors: Real-world efficacy and safety analysis

Xiaodong Feng, Lijun Fan, Aiping Chen, J. Zhang, Yuwei Xia, Z. Li, Yan Yin, Zi‐Niu Ding, Lingling Wang, Min Wang, Xu Che, Hongrui Wang, Xin Wu, Huiying Sun, Yun Jin, Yiqiang Liu, Meng Pang, Xiangjian Zhang, Min Liu
article en

Abstract

Ripretinib has emerged as a promising second-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs), demonstrating comparable efficacy to sunitinib and a superior safety profile. However, the optimal second-line therapy tailored to individual patient characteristics remains underexplored. This prospective, multicenter, observational study (NCT05440357) aims to evaluate real-world patterns and outcomes for GISTs patients.

ESMO OpenVol. 10
Sun Yat-sen University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), West China Hospital of Sichuan University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Fuyang City People's Hospital (CN), Deyang Stomatological Hospital (CN), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN), Sichuan Cancer Hospital (CN), Fuzhou General Hospital of Nanjing Military Command (CN), Peking University Shenzhen Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Chengdu Fifth People's Hospital (CN), Taiyuan Central Hospital (CN), Sun Yat-sen University Cancer Center (CN), Guangdong Provincial People's Hospital (CN), Chongqing Cancer Hospital (CN), Chongqing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 93%
Gastrointestinal Tumor Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.